Method Development, Validation and Degradation Studies of Imatinib Mesylate by UPLC

Venkateshwarlu, Punna and Patel, Mehul M. (2021) Method Development, Validation and Degradation Studies of Imatinib Mesylate by UPLC. Journal of Pharmaceutical Research International, 33 (62A). pp. 330-340. ISSN 2456-9119

[thumbnail of 5341-Article Text-7465-2-10-20221006.pdf] Text
5341-Article Text-7465-2-10-20221006.pdf - Published Version

Download (572kB)

Abstract

Background: A simple, reliable and economical method was used for the study of imatinib mesylate. The optimized chromatographic conditions were determined by using a C18 intersil ODS (250 X 4.6 mm X 5µm) and a mobile phase containing phosphate buffer (pH 3.0): Acetonitrile: Methanol (40:30:30) v/v was pumped at 1 ml/min flow rate. The injected sample volume is 20 μL and the analytes were eluted at 254 nm.

Results: The Retention time of imatinib mesylate was 3.503 minutes. The system suitability percentage RSD of imatinib mesylate is 0.27. The Assay of imatinib mesylate was found to be 99.37%.The imatinib mesylate LOD, LOQ values of were found to be 0.901 and 2.73μg/ml. Regression equation was found to be y= 96.59x + 10.76 form linearity calibration graph. Imatinib mesylate was degraded in acid and peroxide stress conditions, and no degradation was obtained in base, photolytic and thermal conditions.

Conclusion: The reliable UPLC method validation data observed that which can be used for analyzing routine quality control. The method is economical due to the run time is reduced, which can be used in regular quality control tests in the industry.

Item Type: Article
Subjects: Article Paper Librarian > Medical Science
Depositing User: Unnamed user with email support@article.paperlibrarian.com
Date Deposited: 24 Feb 2023 09:37
Last Modified: 30 Dec 2023 13:31
URI: http://editor.journal7sub.com/id/eprint/110

Actions (login required)

View Item
View Item